Arcutis Biotherapeutics (ARQT) Change in Cash (2019 - 2026)

Arcutis Biotherapeutics' Change in Cash history runs 8 years deep, the most recent figure standing at -$8.1 million for Q1 2026.

• In Q1 2026, Change in Cash rose 55.32% year-over-year to -$8.1 million; the TTM figure through Mar 2026 stood at -$18.7 million (up 86.39% YoY), while the FY2025 annual figure was -$28.7 million, down 65.43% from the prior year.
• Change in Cash for Q1 2026 stood at -$8.1 million, down from -$4.2 million in the prior quarter.
• The five-year high for Change in Cash was $101.4 million in Q1 2024, with the low at -$105.8 million in Q2 2024.
• The 5-year median for Change in Cash is -$8.1 million (2026), against an average of -$3.7 million.
• Peak annual rise in Change in Cash reached 2045.99% in 2024, while the deepest fall reached 546.36% in 2024.
• Arcutis Biotherapeutics' Change in Cash stood at -$27.9 million in 2022, then surged by 31.64% to -$19.1 million in 2023, then slumped by 233.02% to -$63.5 million in 2024, then soared by 93.37% to -$4.2 million in 2025, then plunged by 93.33% to -$8.1 million in 2026.
• Business Quant data shows ARQT's Change in Cash at -$8.1 million in Q1 2026, -$4.2 million in Q4 2025, and -$25.6 million in Q3 2025.